SCHEMBL27467102

SCHEMBL27467102

NCc1ccc(NC(=O)c2cccc(N)c2Cc2ccncc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 6/20 0.54
▸ MAPT P10636 4/20 0.54
▸ LMNA P02545 7/20 0.52
▸ KLKB1 P03952 3/20 0.51
▸ PRKCI P41743 2/20 0.51
▸ NPC1 O15118 1/20 0.49
▸ TP53 P04637 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ ALDH1A1 P00352 4/20 0.47
▸ HTT P42858 3/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ NPSR1 Q6W5P4 2/20 0.47
▸ KDR P35968 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ PLG P00747 1/20 0.46
▸ KLK1 P06870 1/20 0.46
▸ KLK6 Q92876 1/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ GAA P10253 1/20 0.46
▸ HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27486254 0.90 SMN1; SMN2 (0.53) SMN1; SMN2MAPTLMNAPRKCIALDH1A1
SCHEMBL27485938 0.90 PRKCI (0.53) SMN1; SMN2MAPTLMNAPRKCINPC1
SCHEMBL27609433 0.89 ALDH1A1 (0.52) SMN1; SMN2MAPTLMNAPRKCINPC1
SCHEMBL27486256 0.89 KDR (0.57) SMN1; SMN2MAPTLMNANPC1ALDH1A1
SCHEMBL27485248 0.85 KDR (0.59) SMN1; SMN2MAPTLMNANPC1RAB9A
SCHEMBL27485244 0.84 ALDH1A1 (0.52) SMN1; SMN2MAPTLMNANPC1TP53
SCHEMBL27468045 0.83 KDR (0.44) SMN1; SMN2MAPTLMNAPRKCIALDH1A1
SCHEMBL27548625 0.82 KDR (0.59) SMN1; SMN2MAPTALDH1A1KDRKMT2A
SCHEMBL27548627 0.82 NPC1 (0.41) SMN1; SMN2MAPTLMNAPRKCINPC1
SCHEMBL27484538 0.82 CYP17A1 (0.56) SMN1; SMN2MAPTLMNANPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN claimed
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN disclosed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN disclosed
Send feedback